Time to reduce implementation gaps of lipid-lowering therapy
Video navigation menu
- ESC/EAS risk-based LDL-c goals 00:56
- The basis of the lower LDL-c recommendation for clinical practice 01:58
- Use of lipid-lowering treatments and their impact on health and disease outcomes 02:32
- Implementation gaps and how combination therapy can overcome this 04:04
- Summary 08:58
This presentation by Prof. Kausik Ray, MD was part of the EBAC-accredited symposium "PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities" held during the virtual ESC Congress 2020.
Prof. Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Sanofi and Amgen
This is available as accredited online CME for members. Click the button below to enroll:Enroll
Share this page with your colleagues and friends: